Related Experiment Video
Updated: Nov 14, 2025

Localization of SUMO-modified Proteins Using Fluorescent Sumo-trapping Proteins
Published on: April 27, 2019
The activity of the EMT suppressor GRHL2 is regulated by SUMOylation
Sonja Santjer1, Yang Xu1, Sabine Riethdorf1
1Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Abstract:
The developmental transcription factor grainyhead-like 2 (GRHL2) has been attributed both tumor-suppressive and protumorigenic functions in a large variety of human cancers. Despite its fundamental role in cancer development and progression, mechanisms modulating expression or activity of GRHL2 in cancer cells still remain elusive. We identified several components of the SUMOylation machinery as candidate GRHL2 interactors using a yeast two-hybrid screening approach and a single major GRHL2 SUMOylation site at lysine residue 159. SUMOylation of GRHL2 at lysine 159 enhances its transcriptional activity and was found to be stimulated by phosphorylation of GRHL2 at threonine 164 by p38α/β MAPKs or by interaction with members of the PIAS family of SUMO E3 ligases. Additionally, structural analysis identified GRHL2 as an intrinsically disordered protein with a high propensity to misfold and to form aggresome-like structures in the nucleus, resulting in repression of GRHL2 transcriptional activity. Results obtained by immunohistochemical analysis of GRHL2 expression in primary breast cancers support an important role of GRHL2 subnuclear compartmentalization in breast carcinogenesis. Taken together, our results provide new insights into complex regulatory mechanisms governing GRHL2 activity in cancer cells.
Insights
The developmental transcription factor grainyhead-like 2 (GRHL2) is regulated by SUMOylation and phosphorylation, impacting its activity in cancer. Misfolding and nuclear aggresome formation also repress GRHL2, highlighting complex control mechanisms in carcinogenesis.
Area of Science:
- Molecular Biology
- Cancer Biology
- Biochemistry
Background:
- The transcription factor grainyhead-like 2 (GRHL2) has dual roles in cancer, acting as both a tumor suppressor and promoter.
- Mechanisms controlling GRHL2 expression and activity in cancer remain largely unknown.
Purpose of the Study:
- To elucidate the regulatory mechanisms governing GRHL2 activity in cancer cells.
- To identify post-translational modifications and structural properties influencing GRHL2 function.
Main Methods:
- Yeast two-hybrid screening to identify GRHL2 interactors.
- SUMOylation and phosphorylation site mapping (Lysine 159, Threonine 164).
- Structural analysis of GRHL2, including propensity for misfolding and aggresome formation.
- Immunohistochemical analysis of GRHL2 in breast cancer tissues.
Main Results:
- Identified SUMOylation machinery components as GRHL2 interactors.
- Discovered a key SUMOylation site (Lysine 159) that enhances GRHL2 transcriptional activity.
- Found that p38α/β MAPKs phosphorylation (Threonine 164) and PIAS E3 ligase interaction stimulate GRHL2 SUMOylation.
- Characterized GRHL2 as an intrinsically disordered protein prone to nuclear misfolding and aggresome formation, leading to transcriptional repression.
- Demonstrated the significance of GRHL2 subnuclear localization in breast carcinogenesis.
Conclusions:
- GRHL2 activity is intricately regulated by SUMOylation and phosphorylation, with specific sites modulating its function.
- GRHL2's intrinsically disordered nature contributes to its regulation through misfolding and aggresome formation.
- Subnuclear compartmentalization of GRHL2 plays a critical role in breast cancer development.
Related Concept Videos
Co-activators and Co-repressors
Regulation of Expression at Multiple Steps
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Regulation of Nuclear Protein Sorting
RNA Polymerase II Accessory Proteins
Regulation of the Unfolded Protein Response

